Albireo Pharma Investor Relations Material

Albireo Pharma, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company has several product candidates, including BELVIQ®, ALBENZA® and DIFICID®. The company's customers are physicians and patients that use these pharmaceutical products with an integrated sales force that markets directly to non-hospital clinicians (primary care physicians).